NCT00197093View on ClinicalTrials.gov

In-Patient Study In Schizophrenic Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2004

Conditions
Schizophrenia
Interventions
DRUG

SB773812

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY